As expected, the crebKO organoids grew less efficiently than the WT organoids, however, beyond this baseline difference, colony numbers and growth assessed by the MTT assay indicated that loss of CREB further sensitizes primary intestinal cells to the cytotoxic effects of the CRC chemotherapeutic drug (Figure 8). Here, CREB1 is linked to colorectal carcinoma.